Alzheimer’s

A recent study suggests that time-limited eating, a form of intermittent fasting, may alleviate circadian disruptions in Alzheimer’s disease in …

Discoveries on ABCA7: Potential Alzheimer’s Therapy Through Cholesterol and Inflammation Insights.

MIT scientists conduct extensive research on Alzheimer’s, studying genomic, epigenomic, and transcriptomic alterations in over 2 million brain cells. They …

Researchers at Chalmers University have shown that graphene oxide nanoflakes can effectively reduce the toxicity of amyloid peptides in a …

This comprehensive study reveals that only a small percentage of older adults with early Alzheimer’s symptoms are eligible for new …

Experiencing Hot Flashes During Sleep May Be an Early Indicator of Alzheimer’s DiseaseA recent study utilizing blood-based biomarkers for Alzheimer’s …

Pioneering research highlights a marked deficiency of key antioxidants like lutein and zeaxanthin in Alzheimer’s patients’ brains, suggesting that a …

MIT’s A11 Drug: Promising Alzheimer’s Treatment Reducing Inflammation and Enhancing Memory in Preclinical Trials.

Researchers from Laval University and the University of Lethbridge identify a new therapeutic target in Alzheimer’s disease. Reactivating the neuron-regulating …

A comprehensive study reveals over 11,000 unique circRNAs in brain cells linked to Parkinson’s and Alzheimer’s, offering new insights into …